ロード中...
Use of Allopurinol to Mitigate 6-Mercaptopurine Associated Gastrointestinal Toxicity in Acute Lymphoblastic Leukemia
An essential component of acute lymphoblastic leukemia (ALL) therapy is the prolonged maintenance phase with daily 6-mercaptopurine (6-MP) as the cornerstone. While 6-MP is generally well-tolerated, some patients suffer from significant side effects such as gastrointestinal (GI) toxicity, including...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7378397/ https://ncbi.nlm.nih.gov/pubmed/32766146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01129 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|